Etienne Rouleau

发表

Correction: Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

Patricia Marino, Rajae Touzani, Lionel Perrier, 2018, European Journal of Human Genetics.

Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

Etienne Rouleau, Christophe Béroud, Sandrine Caputo, 2011, Nucleic Acids Res..

Laboratory and quality management: “European external quality assessment for the improvement of KRAS testing

J.H.J.M. van Krieken, Etienne Rouleau, Els Dequeker, 2011 .

BRCA1 and BRCA2 5′ noncoding region variants identified in breast cancer patients alter promoter activity and protein binding

Etienne Rouleau, Paolo Peterlongo, Eliseos J Mucaki, 2018, Human mutation.

Multiple sequence variants of BRCA2 exon 7 alter splicing regulation

Etienne Rouleau, Dominique Vaur, Sophie Krieger, 2012, Journal of Medical Genetics.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

PIK3R1 underexpression is an independent prognostic marker in breast cancer

Etienne Rouleau, Rosette Lidereau, Didier Meseure, 2013, BMC Cancer.

Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study

Lionel Perrier, Isabelle Durand-Zaleski, Rajae Touzani, 2018, European Journal of Human Genetics.

Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients

Etienne Rouleau, Cécile Jovelet, Steven Blanchard, 2017, PloS one.

Guidance for laboratories performing molecular pathology for cancer patients

Etienne Rouleau, Manfred Dietel, Ed Schuuring, 2014, Journal of Clinical Pathology.

Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL

Etienne Rouleau, Michael Hummel, Antonio Marchetti, 2016, Virchows Archiv.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Non-Coding Variants in BRCA1 and BRCA2 Genes: Potential Impact on Breast and Ovarian Cancer Predisposition

Leslie Burke, Etienne Rouleau, Dominique Stoppa-Lyonnet, 2018, Cancers.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of BRCA1 BRCT Variants on Cancer Risk

Jean-Christophe Aude, Etienne Rouleau, Sandrine M. Caputo, 2018, Molecular Cancer Research.

Guidelines for splicing analysis in molecular diagnosis derived from a set of 327 combined in silico/in vitro studies on BRCA1 and BRCA2 variants

Jean-Philippe Vert, Etienne Rouleau, Sophie Krieger, 2012, Human mutation.

A guide for functional analysis of BRCA1 variants of uncertain significance

Etienne Rouleau, Aneliya Velkova, Alvaro Galli, 2012, Human mutation.

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials

Roman Rouzier, Etienne Rouleau, Nicolas Servant, 2015, Journal of the National Cancer Institute.